|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Capitalization1 |
401 | 704 | 93,3 | 4 079 | 10 817 | 938 | 938 | - |
Enterprise Value (EV)1 |
612 | 931 | 335 | 3 836 | 9 756 | -517 | -508 | 2,70 |
P/E ratio |
-1,97x | -3,68x | -0,72x | -15,3x | -6,10x | -1,53x | -1,84x | -2,60x |
Yield |
- | - | - | - | - | - | - | - |
Capitalization / Revenue |
12,9x | 20,5x | 5,00x | 8,58x | 9,44x | 0,48x | 0,76x | 0,91x |
EV / Revenue |
19,6x | 27,2x | 18,0x | 8,07x | 8,51x | -0,27x | -0,41x | 0,00x |
EV / EBITDA |
-3,97x | -5,62x | - | - | - | 1,14x | 1,02x | - |
Enterprise Value (EV) / FCF |
-4,28x | -5,00x | -2,42x | -39,5x | 36,8x | 1,68x | 0,97x | -0,02x |
FCF Yield |
-23,3% | -20,0% | -41,3% | -2,53% | 2,72% | 59,6% | 103% | -4 317% |
Price to Book |
-3,95x | -4,21x | -0,69x | 12,6x | -30,9x | -1,69x | -2,18x | -1,02x |
Nbr of stocks (in thousands) |
16 161 | 19 143 | 23 449 | 36 578 | 75 608 | 85 979 | 85 979 | - |
Reference price (USD) |
24,8 | 36,8 | 3,98 | 112 | 143 | 10,9 | 10,9 | 10,9 |
Announcement Date |
03/14/2018 | 03/18/2019 | 03/11/2020 | 03/01/2021 | 02/28/2022 | - | - | - |
1 USD in Million |
|
|
Income Statement Evolution (Annual data) |
|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Net sales1 |
31,2 | 34,3 | 18,7 | 476 | 1 146 | 1 947 | 1 233 | 1 036 |
EBITDA1 |
-154 | -166 | - | - | - | -455 | -499 | - |
Operating profit (EBIT)1 |
-172 | -174 | -130 | -417 | -1 687 | -480 | -474 | -307 |
Operating Margin |
-551% | -507% | -694% | -87,6% | -147% | -24,7% | -38,5% | -29,6% |
Pre-Tax Profit (EBT)1 |
-184 | -185 | -133 | -418 | -1 715 | -548 | -479 | -314 |
Net income1 |
-184 | -185 | -133 | -418 | -1 744 | -535 | -487 | -337 |
Net margin |
-589% | -539% | -711% | -87,9% | -152% | -27,5% | -39,5% | -32,5% |
EPS2 |
-12,6 | -10,0 | -5,51 | -7,27 | -23,4 | -7,12 | -5,93 | -4,20 |
Free Cash Flow1 |
-143 | -186 | -138 | -97,2 | 265 | -309 | -525 | -117 |
FCF margin |
-458% | -543% | -742% | -20,4% | 23,2% | -15,8% | -42,5% | -11,2% |
FCF Conversion |
92,7% | 112% | - | - | - | 67,9% | 105% | - |
Dividend per Share2 |
- | - | - | - | - | - | - | - |
Announcement Date |
03/14/2018 | 03/18/2019 | 03/11/2020 | 03/01/2021 | 02/28/2022 | - | - | - |
1 USD in Million 2 USD |
|
|
Income Statement Evolution (Quarterly data) |
|
Fiscal Period: December
|
2020 Q2 |
2020 Q3 |
2020 Q4 |
2021 Q1 |
2021 Q2 |
2021 Q3 |
2021 Q4 |
2022 Q1 |
2022 Q2 |
2022 Q3 |
2022 Q4 |
2023 Q1 |
2023 Q2 |
2023 Q3 |
2023 Q4 |
Net sales1 |
35,5 | 157 | 280 | 447 | 298 | 179 | 222 | 704 | 186 | 735 | 365 | 368 | 365 | 402 | 481 |
EBITDA |
- | - | - | - | - | - | - | - | - | -119 | - | - | - | - | - |
Operating profit (EBIT)1 |
-17,0 | -194 | -183 | -209 | -346 | -307 | -825 | 209 | -483 | -127 | -93,3 | -122 | -88,9 | -53,5 | 53,3 |
Operating Margin |
-47,9% | -124% | -65,4% | -46,6% | -116% | -172% | -371% | 29,7% | -260% | -17,3% | -25,6% | -33,2% | -24,4% | -13,3% | 11,1% |
Pre-Tax Profit (EBT)1 |
-17,5 | -197 | -178 | -220 | -349 | -316 | -830 | 206 | -509 | -166 | -91,6 | -124 | -91,1 | -55,7 | 51,1 |
Net income1 |
-17,5 | -197 | -178 | -223 | -352 | -322 | -846 | 203 | -510 | -169 | -80,4 | -118 | -86,5 | -52,9 | 48,5 |
Net margin |
-49,3% | -126% | -63,5% | -49,8% | -118% | -180% | -381% | 28,9% | -275% | -23,0% | -22,1% | -32,1% | -23,7% | -13,2% | 10,1% |
EPS2 |
-0,30 | -3,21 | -2,70 | -3,05 | -4,75 | -4,31 | -11,2 | 2,56 | -6,53 | -2,15 | -1,14 | -1,71 | -1,63 | -1,24 | -0,72 |
Dividend per Share |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date |
08/10/2020 | 11/09/2020 | 03/01/2021 | 05/10/2021 | 08/05/2021 | 11/04/2021 | 02/28/2022 | 05/09/2022 | 08/08/2022 | 11/08/2022 | - | - | - | - | - |
1 USD in Million 2 USD |
|
|
|
Fiscal Period: December
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Net Debt1 |
211 | 227 | 242 | - | - | - | - | - |
Net Cash position1 |
- | - | - | 243 | 1 061 | 1 455 | 1 446 | 935 |
Leverage (Debt / EBITDA) |
-1,37x | -1,37x | - | - | - | 3,20x | 2,89x | - |
Free Cash Flow1 |
-143 | -186 | -138 | -97,2 | 265 | -309 | -525 | -117 |
ROE (Net Profit / Equities) |
- | - | - | -190% | -1 266% | - | - | - |
Shareholders' equity1 |
- | - | - | 221 | 138 | - | - | - |
ROA (Net Profit / Asset) |
-52,7% | -72,4% | -74,4% | -47,7% | -83,8% | -17,3% | -26,3% | -39,6% |
Assets1 |
348 | 255 | 178 | 878 | 2 080 | 3 091 | 1 852 | 850 |
Book Value Per Share2 |
-6,29 | -8,74 | -5,75 | 8,84 | -4,64 | -6,44 | -5,01 | -10,7 |
Cash Flow per Share2 |
- | - | - | - | - | -6,18 | -8,60 | - |
Capex1 |
4,19 | 1,37 | 1,86 | 220 | 57,5 | 75,5 | 66,3 | 37,5 |
Capex / Sales |
13,4% | 4,00% | 9,95% | 46,3% | 5,01% | 3,87% | 5,38% | 3,62% |
Announcement Date |
03/14/2018 | 03/18/2019 | 03/11/2020 | 03/01/2021 | 02/28/2022 | - | - | - |
1 USD in Million 2 USD |
|
| |
|
|
Novavax cuts full-year revenue forecast |
Capitalization (USD) |
938 030 366 |
Net sales (USD) |
1 146 290 000 |
Number of employees |
1 541 |
Sales / Employee (USD) |
743 861 |
Free-Float |
98,6% |
Free-Float capitalization (USD) |
925 118 066 |
Avg. Exchange 20 sessions (USD) |
77 506 587 |
Average Daily Capital Traded |
8,26% |
|